Back to Journals » OncoTargets and Therapy » Volume 16

Case report

Sustained Clinical Response to 4th-Line Therapy with Selpercatinib in RET Fusion-Positive Combined Small Cell Lung Cancer

       
Total article views   HTML views PDF downloads Totals
2,366 Dovepress* 2,230+ 64 2,294
PubMed Central* 136 41 177
Totals 2,366 105 2,471
*Since 29 November 2023

View citations on PubMed Central and Google Scholar